Posted: January 26th, 2018

Interleukin-2 (IL-2) is used as adjuvant therapy for a patient with metastatic renal cell carcinoma. The nurse teaches the patient that the most important purpose of therapy with this agent is to

Interleukin-2 (IL-2) is used as adjuvant therapy for a patient with metastatic renal cell carcinoma.

The nurse teaches the patient that the purpose of therapy with this agent is to

A. protect normal kidney cells from the damaging effects of chemotherapy.
B. enhance the patient’s immunologic response to tumor cells.
C. stimulate malignant cells in the resting phase to enter mitosis.
D. prevent the bone marrow depression caused by chemotherapy.